Opella Resumes Manufacturing of Mucosolvan Syrup for Adults
Opella has announced the reactivation of Mucosolvan Syrup Adult 6mg/ml (120 ml) manufacturing and commercialization following regulatory notification in Brazil. The product is now available.
Brazil: Pharmaceutical company Opella has resumed the manufacturing and commercialization of its Mucosolvan Syrup Adult 6mg/ml (120 ml). The company submitted the notification for the reactivation of the medicine's production to the Brazilian National Health Surveillance Agency (ANVISA) on August 21, 2026.
With this regulatory step, the product's commercialization has been normalized. Opella noted that logistics for delivery may vary by region and advised consumers to check product availability in their local areas.
Mucosolvan is a mucolytic agent used to treat respiratory conditions involving mucus. The resumption of manufacturing ensures that patients who rely on the medication for symptom relief can access it consistently.
Opella has provided customer service contact information for further inquiries. The company's action aims to ensure the continued availability of the medicine in the market.